$TOMZ

TOMI study shows pathogen reduction in food processing

TOMI Environmental Solutions (TOMZ) reported that its SteraMist iHP product significantly reduced Listeria monocytogenes in food processing facilities, according to an independent study. The treatment achieved over 7 log reduction on flat surfaces and over 3 log on equipment parts. The global food sanitation market is projected to grow to $17.4B by 2035, according to Global Market Insights.

Original reporting
Published Oct 15, 2026, 12:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 1:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefTechnology
Primary signal
$TOMZ
Bullish
medium confidence
Mentioned
$TOMZ
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$TOMZBullishLow
01

Why it matters

The new study provides the first independent validation of its SteraMist iHP product against Listeria, a major food‑borne pathogen, potentially opening new contracts in food processing.

02

Market read

The study could boost TOMZ's visibility and lead to new sales, but scale and execution remain uncertain.

03

What to watch

The study does not address cost, regulatory approvals, or competitive landscape, which could limit adoption.

Relevance 5/10Novelty 6/10Timing: same‑day release

Background

TOMI Environmental Solutions (NASDAQ:TOMZ) develops binary ionization technology for disinfection across multiple sectors.

Company-level read

Ticker impact

$TOMZBullishMedium confidence
Context

TOMI Environmental Solutions released an independent lab study showing its SteraMist iHP product reduced Listeria monocytogenes by >7 log on flat surfaces.

Expected impact

potential upside as investors price in the new efficacy data and possible contract wins in food safety.

Evidence & confidence

Novel efficacy results address a key pain point for food processors; no prior data existed, but the company is small and the market impact may be limited.

Market effects

Highlights growing demand for advanced sanitation solutions in food processing, may benefit peers in industrial hygiene.

U.S. food safety regulators may reference the data, but immediate regional effect is limited.

Shows potential for broader adoption of ionized hydrogen peroxide technology worldwide.

Counterpoint

Efficacy in lab settings may not translate to commercial scale; investors should weigh execution risk.

Key entities

  • TOMI Environmental Solutions, Inc.

    Developer of SteraMist iHP disinfection technology.

  • Josh Hasty, Ph.D.

    CEO of FH Services, partner to commercialize the study data.

Related articles

$TOMZHighAI 8/10

Tomi Environmental stock surges on canceled merger deal

Tomi Environmental Solutions Inc (TOMZ) shares rose 15% after-hours Monday after terminating its merger agreement with Carbonium Core Inc. The companies agreed the deal was no longer strategically or financially beneficial. CEO Dr. Halden Shane cited strong business performance and focus on shareholder value. TOMZ provides disinfection and decontamination solutions.

$TOMZMed

TOMI Environmental Solutions, Inc. Reports Second Quarter 2026 Financial Results

TOMI Environmental Solutions, Inc. (TOMZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 FOR IMMEDIATE RELEASE TOMI Environmental Solutions, Inc. Reports Second Quarter 2026 Financial Results Company Delivers 118% Q2 Revenue Growth, Reaffirms Full-Year 2026 Guidance of $12 Million (113% YoY Growth) FREDERICK, Md., August 14, 2026 (GLOBE NEWSWIRE) -- TOMI

$TOMZMed

TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages

TOMI Environmental Solutions, Inc. (TOMZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages -Carbonium Merger Remains on Track -European Regulatory Expansion and Partnership Growth -Advancement of B

$TOMZMed

TOMI Environmental Solutions, Inc.: TOMI Environmental Solutions Reaffirms $12 Million Revenue Guidance for Fiscal 2026 and Confirms $35 Million Sales Pipeline with $8.6 Million in Advanced Stages

TOMI Environmental Solutions (NASDAQ: TOMZ) reaffirmed fiscal 2026 revenue guidance of at least $12 million and said it has a $35 million sales pipeline, including about $8.6 million in advanced stages. The company reported booked orders of $6.2 million and Q2 growth across key metrics. TOMI also said its Carbonium merger remains on track for H2 2026.

$TOMZMedAI 8/10

TOMI Reports 124% Increase in Preliminary Second Quarter Revenue; Preliminary Six Months Revenue Combined with Open Orders Surpass Full Year 2025 Revenue

TOMI Environmental Solutions (NASDAQ: TOMZ) reported preliminary Q2 2026 revenue of about $2.3 million, up 124% year over year, and said open orders of $6.2 million already exceed full-year 2025 revenue. It cited higher revenue across equipment, accessories, support services, applicators, and BIT Solution, with gross margin at 70%.

$TOMZMedAI 9/10

Global Norovirus Outbreaks, Ebola Emergency and Rising Disease Threats Highlight Growing Need for TOMI Environmental Solutions' SteraMist Technology

TOMI Environmental Solutions (NASDAQ: TOMZ) said NASA selected its SteraMist ionized hydrogen peroxide (iHP) technology for a Mars Sample Return biosecurity operation. The company also cited rising infectious-disease alerts, including norovirus outbreaks and Ebola-related concerns, as driving demand for scalable disinfection in hospitals, hotels, cruise lines, schools and government sites.